Stereotactic body radiotherapy for recurrent hemoptysis due to chronic pulmonary aspergillosis: a case report and systematic review of the literature.

Koch, Alexander; Schanne, Daniel H; Günther, Gunar; Aebersold, Daniel M; Eliçin, Olgun (2023). Stereotactic body radiotherapy for recurrent hemoptysis due to chronic pulmonary aspergillosis: a case report and systematic review of the literature. Strahlentherapie und Onkologie, 199(2), pp. 192-200. Springer 10.1007/s00066-022-02013-1

[img]
Preview
Text
s00066-022-02013-1.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

PURPOSE

Chronic pulmonary aspergillosis (CPA) can manifest as fungus balls in preexisting cavities of lung parenchyma and recurrent hemoptysis is among the most frequent complications. Radiotherapy can be considered for treatment-refractory aspergilloma and severe hemoptysis. To the best of our knowledge, we present the first application of stereotactic body radiotherapy (SBRT) for a pulmonary aspergilloma in a patient with limited functional lung capacity. The topic was further expanded on with a systematic review of the literature addressing the implementation of radiotherapy in CPA patients.

CASE REPORT

A 52-year-old man presented with recurring and treatment-refractory hemoptysis caused by chronic cavitary aspergillosis localized in the left lower lobe. We applied SBRT on two consecutive days with a total dose of 16 Gy. Hemoptysis frequency decreased to a clinically insignificant level.

SYSTEMATIC REVIEW

We performed a systematic search of the literature in line with the PRISMA statement. The initial PubMed search resulted in 230 articles, of which 9 were included.

RESULTS

The available literature contained 35 patients with CPA who received radiotherapy. Dose fractionation usually ranged from 2 to 4 Gy per fraction, applied almost exclusively in conventional two-dimensional (2D) techniques. There is no report of SBRT usage in such a scenario. Most cases report a positive treatment response after irradiation.

CONCLUSION

The presented case demonstrates long-term clinical stability after SBRT for recurrent hemoptysis due to pulmonary aspergilloma. The systematic literature search revealed that concept definition is still uncertain, and further work is necessary to establish radiotherapy in clinical practice.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Koch, Alexander, Schanne, Daniel Hendrik, Günther, Gunar, Aebersold, Daniel Matthias, Eliçin, Olgun

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1439-099X

Publisher:

Springer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

21 Oct 2022 10:14

Last Modified:

26 Jan 2023 00:13

Publisher DOI:

10.1007/s00066-022-02013-1

PubMed ID:

36264357

Uncontrolled Keywords:

Aspergilloma CPA Mycetoma Post-tuberculosis lung disease SBRT

BORIS DOI:

10.48350/173976

URI:

https://boris.unibe.ch/id/eprint/173976

Actions (login required)

Edit item Edit item
Provide Feedback